Although the concept that CB2 activation may be beneficial in AD was further supported by a recent study demonstrating the efficiency of a CB2-activating Echinacea purpurea extract in alleviating AD symptoms [199], a few additional data argue that the overall picture may be more complex. Here, CNR2 is linked to Alzheimer disease.